Pharmaceutical company spending on research and development and promotion in Canada, 2013-2016: a cohort analysis

BACKGROUND: Competing claims are made about the amount of money that pharmaceutical companies spend on research and development (R&D) versus promotion. This study investigates this question in the Canadian context. METHODS: Two methods for determining industry-wide figures for spending on promot...

Descripción completa

Detalles Bibliográficos
Autor principal: Lexchin, Joel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5848527/
https://www.ncbi.nlm.nih.gov/pubmed/29564139
http://dx.doi.org/10.1186/s40545-018-0132-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5848527/
https://www.ncbi.nlm.nih.gov/pubmed/29564139
http://dx.doi.org/10.1186/s40545-018-0132-3

Ejemplares similares